Literature DB >> 1918957

The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine.

S Sozzani1, W Luini, M Molino, P Jílek, B Bottazzi, C Cerletti, K Matsushima, A Mantovani.   

Abstract

Recombinant monocyte-chemotactic and activating factor (rMCAF; alternative acronyms MCP-1, TDCF, human JE) induced migration of human monocytes across polycarbonate or nitrocellulose filters. Maximal induction of migration was observed at a concentration of 10 ng/ml (10(-9) M). Checkerboard analysis revealed that rMCAF elicited true gradient-dependent chemotactic migration, although a gradient independent chemokinetic effect was observed at low concentrations (1-5 ng/ml). rMCAF caused a rapid (less than 5 s) and transient (approximately 1.5 min) increase of free cytosolic Ca2+ ions, as assessed by the fura-2 probe. No Ca2+ increase was detected in neutrophils or lymphocytes stimulated by rMCAF. Studies conducted in the absence of extracellular Ca2+ or in the presence of Ni2+ (an inhibitor of Ca2+ influx) suggested that the increase of intracellular Ca2+ induced by rMCAF is dependent on the influx of extracellular Ca2+ through plasma membrane channels. Bordetella pertussis toxin inhibited the intracellular Ca2+ elevation and chemotaxis caused by rMCAF. The possible involvement of Ca(2+)-dependent protein kinases in rMCAF signaling pathway(s) was explored using inhibitors. Inhibitors of GMP-dependent kinase and myosin L chain kinase had no effect on rMCAF-induced monocyte migration. In contrast, protein kinase C/cAMP-dependent kinase inhibitors (such as, C-I, H-7, HA-1004, KT5720, and Staurosporine) markedly decreased rMCAF induced chemotaxis suggesting the involvement of a serine/threonine protein kinase, possibly protein kinase C, in rMCAF signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918957

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.

Authors:  M G Luciani; A Stoppacciaro; G Peri; A Mantovani; L P Ruco
Journal:  Mol Pathol       Date:  1998-10

Review 3.  Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease?

Authors:  Jia L Zhuo
Journal:  J Hypertens       Date:  2004-03       Impact factor: 4.844

4.  Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators.

Authors:  Praveen Thumbikat; Shiva Shahrara; Rudina Sobkoviak; Joseph Done; Richard M Pope; Anthony J Schaeffer
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

5.  Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis.

Authors:  J S Fine; H D Byrnes; P J Zavodny; R W Hipkin
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

6.  A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration.

Authors:  Neda Ghousifam; Hamid Mortazavian; Rudra Bhowmick; Yolanda Vasquez; Frank D Blum; Heather Gappa-Fahlenkamp
Journal:  Int J Biol Macromol       Date:  2016-12-29       Impact factor: 6.953

7.  Enhancement of HIV-1 replication in human macrophages is induced by CD8+ T cell soluble factors.

Authors:  K F Copeland; P J McKay; J J Newton; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

8.  T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo.

Authors:  D D Taub; M Anver; J J Oppenheim; D L Longo; W J Murphy
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

9.  Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists.

Authors:  Elena Riboldi; Giada Frascaroli; Pietro Transidico; Walter Luini; Sergio Bernasconi; Francesca Mancini; Angelo Guglielmotti; Claudio Milanese; Mario Pinza; Silvano Sozzani; Alberto Mantovani
Journal:  Br J Pharmacol       Date:  2003-08-18       Impact factor: 8.739

10.  Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells.

Authors:  K M Thorp; C Southern; N Matthews
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.